System May Enable Precision Medicine in Cancer Care
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
A decision support system called GI TARGET may help integrate precision medicine into routine care for patients with gastrointestinal cancer, according to researchers.
An intervention can increase serious illness conversations and reduce the use of systemic therapy at the end of life in patients with cancer.
US medical oncologists may lack understanding of biosimilars and have limited access to education about these products, a survey suggests.
Using telehealth saved cancer patients an estimated $147.40 to $186.10 per visit, as well as 1.2 hours of in-clinic time and 2.9 hours of roundtrip driving time.
Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
Some patients do not understand common phrases oncologists use, such as “your tumor is progressing” or “your nodes are positive.”
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
The use of oncology hospitalists can reduce readmission rates and improve discharge to hospice, a study suggests.
Medicare’s Oncology Care Model (OCM) did not deter oncologists from prescribing more expensive novel cancer therapies.
The change from 2018 to 2022 could mean 14.8% more penalties and 42.8% fewer bonuses for oncologists.